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Abstract
The prevalence of human papillomavirus (HPV) infection in males is comparable to
females, although in men it is largely unknown. HPV infections may be connected with
the development of carcinomas and other dermoepithelial changes such as intraepithe‐
lial neoplasia. Multidirectional studies have shown that chronic HPV infection is a
necessary, though insufficient factor for the development of cervical cancer. Although
men are regarded as the dominant vector of HPV transmission to their female sexual
partners, they do not develop clinically significant HPV-related lesions and are usually
asymptomatic during relatively short infections.
Analysis of data from a multicenter, clinical preventive trial was to estimate the
incidence of type-specific genital infection among men and HPV transmission
dynamics. The routine clinical examination included a peniscopy and detection of HPV
DNA in smears using hybrid capture and in biopsy material using PCR.
It is necessary to establish prevention strategies for HPV infection in men whose female
sexual partners have cervical cancer. Cervical cancer prevention strategies are likewise
needed and should include the use of prophylactic HPV vaccines.
Keywords: human papillomavirus, genital infection, sexually transmitted disease, cer‐
vical cancer, HPV free
1. Introduction
Numerous infectious, inflammatory, and neoplastic diseases arise in male sexual organs.
Infection of the genitalia with human papillomavirus (HPV) is worldwide and is currently
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the most frequent sexually transmitted infection [1]. For unknown reasons, clinical changes
are  absent  in  most  infected  individuals  as  the  virus  remains  in  a  latent  phase  until
spontaneous elimination occurs by unknown mechanisms.  On the other hand,  immuno‐
suppressed individuals frequently present with the clinical changes caused by HPV. Their
clinical course is more severe, and their therapy is impeded since the immune system is
compromised. Furthermore, genital HPV infections in women and subclinical changes of
various degrees of cervical intraepithelial neoplasia (CIN 1–3) that can pave the way for
the development of cervical cancer are relatively well understood. However, little is known
about  the  subclinical  infections  in  men that  cause  penile  intraepithelial  neoplasia  (PIN).
The  significance  of  PIN is  clear,  since  men who are  carriers  of  HPV can  be  frequently
undiscovered sources of infection for their female sexual partners [2, 3].
2. The risk of HPV infections
HPV is known for its characteristic heterogeneity, and the viral infection can run its
course asymptomatically, subclinically, or symptomatically. Thanks to the polymerase
chain reaction (PCR), over 200 types of HPV have been identified and subsequently
classified according to changes induced, that is high risk (e.g.,  types 16, 18, 31, and 33)
and low risk (e.g.,  6 and 11) [2, 4]. Infection with HPV types 16 and 18 carries a large
risk of precancerous and cancerous changes, while the appearance of genital warts
caused by HPV types 6 and 11 is accompanied by a small risk of cancer development.
Evaluation of risk and detection of HPV infection when clinical symptoms are absent is
possible with a number of investigations, which include peniscopy, hybrid capture II
(HC2), and PCR. The results of tested specimens, however, are variable and largely de‐
pend on anatomic sampling site and method of investigation [5, 6]. For instance, HPV
DNA was found around the glans penis and external prepuce in 24% of individuals
studied, while in 44% it was found on the inner (mucosal) prepuce where low-risk HPV
types predominated. When material was collected using a brush, 70–92% of obtained
samples were positive and 33% of which were high-risk types [6]. Furthermore, the re‐
sults of a peniscopy only suggest the probability of HPV infection, since the presence of
HPV DNA was not confirmed in 57% of positive peniscopy results [5, 7]. Nonetheless,
peniscopy is necessary for gross identification of lesions, and the biopsy allows for his‐
topathologic assessment of character to differentiate inflammatory changes (e.g.,  lichen
sclerosus) from neoplastic changes of low- and high-grade PIN. PCR and HC2 examina‐
tions together with peniscopy allow for evaluation of the infection and defining its risk
group. Also, positive findings upon acetowhitening, PCR, and HC2 are sufficient to es‐
tablish diagnosis [7].
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3. The risk of HPV infection transmission to partners depending on type
of changes
3.1. Genital warts
HPV DNA is detected in approximately 5–11% of sexually active and healthy men aged
16–35 years [8]. The HPV types responsible for the development of genital warts (main‐
ly types 6 and 11) are the predominant cause of infection. Other viral types are strong‐
ly associated with cancer of the cervix and are therefore termed “high-risk” types, and
they include 16, 18, 31, 33, 39, 42, and 51–54 [9]. HPV viruses 16 and 18 are diagnosed
most often in infections running subclinical courses in genital cancer patients. The risk of
infecting sexual partners is estimated at 60%. However, although the peak of infection
detection is in the age of 18–25 years, peak incidence of cervical cancer occurs around
the fifth decade of life. Thus, the process of tumor progression is slow, and additional
factors, so-called cocarcinogens, are necessary for the development of the cancer [10, 11].
Warts are most often multifocal. The following are three main types affecting the geni‐
tal region:
1. genital warts (condyloma acuminata) are the most infectious lesions; they are
pedunculated with a cauliflower-like appearance; depending on location and degree
of irritation, they can be flesh-colored or various shades of red; and in uncircum‐
cised men, they are localized on the inner (mucosal) prepuce, but can also be found
on the glans penis, coronal sulcus, frenulum, external prepuce, shaft of penis, and
scrotum [12].
2. papular, flesh-colored warts, and
3. flat warts—flattened papules of various colors such as red, pink on red, and brown
[8, 13].
Warts may also occur at the urethral meatus or navicular fossa, where they are diag‐
nosed in approximately 28% of patients [8]. In men who use condoms, warts are often
localized in the suprapubic area. Interestingly, apart from prevention, condoms may ac‐
celerate the regression of flat warts on the penis [14]. In addition, they prevent reinfec‐
tion and formation of new growths on the penis, but only when the same type of HPV
occurs in partners. When different HPV types are present in the female partner, con‐
doms do not protect against infection [15]. Condoms minimize the risk of so-called neo‐
plasm transmission because they block the transmission of oncogenic HPV [16]. By
minimizing the risk of penile cancer formation, the risk of cervical cancer is significant‐
ly limited. Moreover, with circumcision, the risk of penile cancer is decreased from 19.6
to 5.5% and subsequently the risk of cervical cancer formation in female sexual partners
is also decreased [17, 18].
In a study of a large number of patients and a group of healthy controls, HPV DNA
was found in 25% of men whose female partners had been diagnosed with CIN. HPV
DNA was found in 6% of healthy women, but there was often discord with the results
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in their partners. Consequently, it has been proposed that no investigations are required
in the absence of clinical changes in the partner of a woman with diagnosed CIN. It is
also emphasized that HPV DNA results be assessed diligently because HPV DNA was
not found in 25% of positive acetowhitening and 57% of those diagnosed with penis‐
copy [19]. In addition, up to 30% of warts have been found to regress spontaneously
over the course of 3 months owing to immune system functions dominated by a cell-
mediated response [10].
The treatment of warts includes the use of podofilox in 0.5% gel or solution, dichloroacetic acid
or trichloroacetic acid, 5% imiquimod cream, cryotherapy with liquid nitrogen, destruction of
tissue with electrofulguration, and laser ablation [20].
3.2. Buschke-Lowenstein tumor
Large warts resembling tumors were first described in 1925 by Buschke and Lowenstein—the
Buschke and Lowenstein tumor [21]. This rare wart variant is associated with HPV infection
types 6 and 11 and is characterized by deep rooting into the stroma that results in damage to
deep-lying tissues. Its aggressive growth produces tumors of large dimensions. Histopatho‐
logically, typically mild warts are found alternating in coexistence with foci of atypical
epithelial cells or cells of highly differentiated squamous cell carcinoma. Patient history is
positive for inflammation or ulceration and phimosis of the glans penis. The warts may ulcerate
or cause fistulation. Diagnosis of this tumor may require multiple biopsies or imaging studies
that include computed tomography (CT) and magnetic resonance imaging (MRI) [22].
3.3. Changes in female partners of men having intraepithelial neoplasia
Intraepithelial neoplasia may involve both male and female genitalia—penile intraepithelial
neoplasia (PIN), cervical intraepithelial neoplasia (CIN), vulvar intraepithelial neoplasia
(VIN), and vaginal intraepithelial neoplasia (VaIN), respectively. Additionally, the anus may
be involved in either gender—anal intraepithelial neoplasia (AIN). The changes can have a
character of bowenoid papulosis or Bowen’s disease. Moreover, female sexual partners of men
with diagnosed PIN can have changes corresponding to CIN, VIN, or VaIN in various degrees
of advancement. They require long-term observation over several months because these
changes often resolve spontaneously. Fortunately, neoplastic transformation of PIN is very
rare [23]. Although the infection status of female partners of men with subclinical infection of
the penis is not determined, it has been accepted that subclinical changes and latent infections
do not require treatment, which would be ineffective in such cases.
3.4. Risk of bowenoid papulosis (BP) development in sexual partners
Bowenoid papulosis (BP), also described as Bowen’s atypia, is an advanced phase of intrae‐
pithelial changes with features of PIN. These warts are generally numerous and tend to form
clusters on the penile shaft and scrotum [22]. In young men, BP resolves spontaneously, but
in the elderly it can maintain itself for years with a tendency to progression. Progression to
squamous cell carcinoma is marked. BP characterizes itself with the occurrence of flat warts
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(papulae) of skin color, but they may also be pink or sometimes brown. In men, it mainly occurs
on the glans, while in women on the labia, groin, and around the anus. It is evoked by HPV
16, but other types (e.g., 18 and 31) may be culprits. The threat to infected women is the
development of cervical cancer; for men, it is that they can infect their female partners and in
doing so predispose them to cervical cancer [24]. Since the presence of BP is entwined with
great risk of cancer development, treatment is considered crucial; excision of the change is
most effective. Cryoablation with liquid nitrogen or laser ablation is also used. Recurrence
should be taken into consideration since it has been estimated as high as 33% [20].
3.5. Erythroplasia of Queyrat
Erythroplasia of the glans penis is a form of carcinoma in situ occurring in uncircumcised men.
Macroscopically, the change is erythematous, well demarcated, and slightly raised above the
level of the skin on the glans penis or on the internal (mucosal) prepuce.
Histologically, it resembles Bowen’s disease; it occurs on mucosal surfaces. The changes are
singular or multiple and painless. Their surface tends to be smooth, scaly, or verrucous. The
most frequent patient complaints are itching and bleeding with difficulties in retracting the
prepuce. Diagnosis is made on the basis of biopsy specimen evaluation. Transformation of
erythroplasia into penile squamous cell carcinoma occurs in 10–33% of patients [25]. Treatment
of choice is surgical excision of the lesions.
3.6. Bowen’s disease
Bowen’s disease is most often observed as a solitary focus that is demarcated, flat, and reddish
in color. Histopathological assessment reveals a squamous cell carcinoma in situ (correspond‐
ing to changes of PIN 3 and VIN 3). The disease is mainly caused by HPV 16 and 18, but
sometimes also by HPV 31, 33, 45, and other oncogenic types. It occurs less often in women,
growing slowly over years though it does not resolve spontaneously. The possibility of
progression to invasive cancer should be considered when induration of the base, ulceration,
or bleeding occurs, or the lesions increase in size. Changes on the vulva classified as intraepi‐
thelial neoplasia VIN 1–3 occur particularly in young women. The possible risk of progression
of VIN3 to invasive cancer should be considered during therapy [22, 26]. In men who are
partners of women with CIN 1–3 or VIN 1–3, changes consistent with PIN 1–3 are relatively
frequent (up to 40%) in comparison with partners of women with genital warts (approximately
5%) [22]. Advanced changes corresponding to PIN 3 are diagnosed more often in older men
in comparison with PIN 1–2. Clinical observations show that BP occurs more often than
Bowen’s disease in younger men [22].
3.7. Penile cancer
Penile cancer is not analogous to cervical cancer. While the detection of HPV DNA approaches
100% in cervical cancer cases, it is found in approximately 40% of penile cancer cases. Differ‐
ences in frequency of finding HPV DNA (50–70%) exist and it depends on the type of cancer.
HPV DNA is diagnosed most often in early premalignant changes corresponding to PIN 3,
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and in warts undergoing malignant transformation. For female sexual partners, infectivity is
greater in cases with PIN 2 and 3 than in those with invasive cancers. The risk of infecting male
partners of women with invasive cancer is not greater than when compared to women with
CIN 2 [27].
Penile cancer is a rarely diagnosed neoplasm (<1% of neoplasms in men) occurring mainly in
older individuals. In recent years, however, this cancer is being diagnosed in younger men. It
predominantly arises on preexisting PIN 3, but, in addition to infection with high-risk
oncogenic HPV types, other factors play a significant role: tobacco smoking, poor hygiene,
phimosis, and changes consistent with lichen sclerosus [28, 29]. When PIN lesions are sus‐
tained, circumcision should be performed for its protective effect.
Chronic infection with oncogenic HPV types, specifically 16 and 18, is the most significant
factor favoring penile cancer. Depending on the method used, HPV DNA is found in up to
90% of penile cancer in such cases. The risk of developing cervical cancer is increased in female
partners of men having penile cancer [30]. As in women, an association between lichen
sclerosus and cancer of genital organs has also been described in men [29, 31]. In one study, it
was shown that neoplastic changes of the penis occur in approximately 8% of men with lichen
sclerosus localized there for 10–23 years [32]. In subsequent studies, it was concluded that
lesions consistent with lichen sclerosus coexisted or preceded penile squamous cell carcinoma
in eight of 20 cases [33]. The etiopathogenesis of lichen sclerosus is unknown, but genetic,
immunologic, infectious (bacteria such as Borrelia), or environmental factors may be possible.
The disease is chronic in character. An association between lichen sclerosus and squamous cell
carcinoma, which is diagnosed in 6% of patients with lesions on the labia, exists in women.
Lichen sclerosus is an inflammatory disease in which involved tissues are affected by atrophic
changes and indurations. Secondary phimosis or induration of the urethral meatus may be
observed in men [31, 33]. In a study of 86 uncircumcised men affected by lichen sclerosus (the
disease most often concerns the uncircumcision of middle age), malignant changes occurred
in five (6%) [32]. The presence of HPV 16 was found in PCR studies while another study found
histologic features of lichen sclerosus in 10 of 20 patients with diagnosed penile squamous cell
carcinoma [33]. A significant role is attributed to genital HPV types. Men affected by lichen
sclerosus report to physicians due to itching and burning sensations, they have painful
erections and difficulties retracting the prepuce, and also they complain of voiding symptoms.
If lichenification involves the glans penis, there is often bleeding, ulceration, and fistulas, and
hemorrhagic bullae may also occur. Progression of changes often expands to involve the glans
penis and prepuce, as well as the frenulum. An indurated white ring around the rim of the
prepuce is a significant finding. It can present with strangulation of the prepuce (paraphimosis)
or phimosis [34, 35]. Genital HPV types are regarded as dominating in the development of
cancer on preexisting lichen sclerosus [36]. It is possible that the long-term inflammation favors
proliferation of epidermal cells and causes activation of the HPV life cycle. Another favoring
factor is local immunosuppression caused by use of preparations containing potent cortico‐
steroids [36]. Due to the risk of phimosis, especially in young men, circumcision is most often
performed following diagnosis of lichen sclerosis.
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Since HPV is a proliferating virus, it should be remembered that it multiplies only in prolif‐
erating cells. Therefore, an underlying inflammatory state or irritation in the genital region
increases the proliferation of epidermis, which in this way supports infection and multiplica‐
tion of the virus. Significantly more often, infections with genital HPV types occur in immu‐
nosuppressed patients, such as those undergoing treatment with cytostatic agents, those after
organ transplant, and also women during pregnancy [37–39]. The clinical course of HPV
infection in patients infected with HIV is very aggressive [40]. The changes caused by HPV are
more extensive in such cases. The risk of progression of preneoplastic lesions into invasive
cancer increases, and the changes occur rapidly. The risk of neoplasm development increases
fivefold in patients after organ transplant [41, 42]. This is linked to HPV infection and impair‐
ment of T lymphocyte and natural killer (NK) cell function by the immunosuppressive
preparations. T lymphocytes and NK cells are responsible for elimination of neoplastic cells
in early oncogenesis [43].
4. Discussion
Most men infected with HPV are naive, either because they have no signs and symptoms or
because the signs and symptoms are so mild that they persist unrecognized or ignored. Men
with HPV infection are a frequent source of infection for their female sexual partners who are
at great risk of death resulting from the development of cervical cancer. Identification of
infected men may reduce transmission and subsequent preneoplastic and neoplastic changes;
however, numerous factors reduce the plausibility of testing men. Unlike the consistent
sampling site in women (the cervix), the sampling site in men varies from anus and perianal
area to the scrotum up to the urethral meatus and into the navicular fossa. Incomplete
anogenital sampling is a major factor contributing to the variability in HPV prevalence
estimates [44]. This variability together with spontaneous elimination of the virus will pose
difficulties for recommendations regarding duration of abstinence and frequency of follow-
up. It has been suggested that for optimal detection, scrotal, perianal, or anal samples should
be included together with the minimum protocol of penile shaft, glans penis, and coronal
sulcus [44].
Surely, we may infer that the knowledge of the presence of HPV infection in the man may
reduce the incidence of cervical cancer in woman by reducing transmission resulting from
proper condom use or sexual abstinence until the virus is eradicated. However, how can the
man be inspired to do comply with such recommendations and what findings can be used to
determine when the man is HPV free and allowed to resume unrestricted coitus? For what
duration and frequency should the man be tested to determine the continued presence of HPV
after the initial positive result? When and for how long should he be tested after changing
partners? This can be considered a serious issue since HPV can be deadly for the woman who
contracts HPV from the unsuspecting man and develops cervical cancer as a result. Yearly
PAP testing for women is already a standard of care in many countries, but what can be done
in developing and underdeveloped countries? How can illiterate populations be educated
about the risks of HPV infection and consequences, and also how they can avoid it? What
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solutions can we implement in poor communities, whose women may not visit their gynecol‐
ogists yearly, or ever? HPV is currently the leading sexually transmitted infection. In countries
where resources are limited or women must travel hours or days by foot to visit their physician,
the implications of late diagnosis may be deadly.
5. Conclusion
In summary, it must be stated that chronic immunosuppression favors HPV infection, allows
for its self-preservation, and also favors activation of the viral life cycle, which is a primary
factor triggering proliferative changes on genital organs. The therapeutic options for HPV-
related changes are numerous (superficial preparations, cryotherapy, laser therapy, surgical
excision) but are unfortunately burdened with recurrence and complications to a large degree.
The changes caused by genital HPV types in the region of the sexual organs demand elimina‐
tion of coexisting inflammatory states and treatment of sexual partners when indicated. It also
appears that using a polyvalent HPV vaccine may prove effective in preventing benign and
malignant changes, especially in groups of patients at increased risk [45]. Vaccination strat‐
egies, however, may be met with difficulties given geographic (e.g., access to facilities), cultural
(e.g., core beliefs), and socio-demographic limitations (e.g., access to information) [46].
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